Related Experiment Video
Updated: May 16, 2026
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Strategies to reverse endothelial dysfunction in diabetic nephropathy
Shawn S Badal1, Farhad R Danesh
1Division of Nephrology, Baylor College of Medicine, Houston, Texas 77030, USA.
Kidney International
|November 16, 2012
Summary
Diabetic nephropathy involves endothelial dysfunction due to low nitric oxide (NO). Enhancing endothelial nitric oxide synthase (eNOS) availability may restore vascular function in these patients.
Area of Science:
- Cardiovascular Science
- Nephrology
- Endocrinology
Background:
- Endothelial dysfunction is central to diabetic microvascular complications.
- Impaired nitric oxide (NO) availability contributes to endothelial dysfunction.
- Endothelial nitric oxide synthase (eNOS) regulates NO production.
Purpose of the Study:
- To investigate the role of eNOS bioavailability in diabetic nephropathy.
- To explore therapeutic strategies targeting eNOS.
Main Methods:
- Review of existing literature on endothelial function in diabetes.
- Analysis of studies investigating eNOS modulation.
- Clinical relevance assessment for diabetic nephropathy.
Main Results:
- Endothelial dysfunction in diabetes is linked to reduced NO.
- eNOS activity is a key factor in NO regulation.
- Cheng et al. suggest eNOS availability is crucial.
Conclusions:
- Restoring endothelial function in diabetic nephropathy may involve increasing eNOS availability.
- Targeting eNOS represents a potential therapeutic avenue.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...